SCHEMBL14611010

SCHEMBL14611010

CNc1cnc(NC2CC2)nc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 3/20 0.50
▸ KDM4E B2RXH2 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ HDAC3 O15379 2/20 0.41
▸ HDAC1 Q13547 2/20 0.41
▸ HDAC2 Q92769 2/20 0.41
▸ HDAC6 Q9UBN7 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ GRM5 P41594 1/20 0.39
▸ ACACB O00763 2/20 0.38
▸ DRD2 P14416 1/20 0.37
▸ DRD3 P35462 1/20 0.37
▸ PDE4A P27815 1/20 0.37
▸ AXL P30530 1/20 0.37
▸ TYRO3 Q06418 1/20 0.37
▸ MERTK Q12866 1/20 0.37
▸ ULK1 O75385 1/20 0.37
▸ CSNK2A1 P68400 1/20 0.36
▸ PIK3C3 Q8NEB9 2/20 0.36
▸ PIK3CD O00329 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2369987 0.78 MAPK1 (0.75) MAPK1KDM4EGAAHDAC3HDAC1
SCHEMBL24220836 0.76 MAPK1 (0.66) MAPK1KDM4EGAAHDAC3HDAC1
SCHEMBL22570292 0.75 MAPK1 (0.46) MAPK1KDM4EGAAHDAC3HDAC1
SCHEMBL21258182 0.74 GRM5 (0.45) KDM4EALDH1A1GRM5ULK1
SCHEMBL2370002 0.74 MAPK1 (0.48) MAPK1KDM4EGAAHDAC3HDAC1
SCHEMBL14865392 0.74 MAPK1 (0.48) MAPK1KDM4EGAAHDAC3HDAC1
SCHEMBL248829 0.74 MAPK1 (0.48) MAPK1KDM4EGAAHDAC3HDAC1
SCHEMBL2949550 0.74 MAPK1 (0.48) MAPK1KDM4EGAAHDAC3HDAC1
SCHEMBL12524651 0.73 MAPK1 (0.49) MAPK1KDM4EGAAHDAC3HDAC1
SCHEMBL18084601 0.73 MAPK1 (0.49) MAPK1KDM4EGAAHDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007022380-A2 BIS-ARYL AMIDE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2007-02-22 — — WO disclosed
Send feedback